行情

NNVC

NNVC

NANOVIRICIDES
AMEX

实时行情|Nasdaq Last Sale

4.180
+0.050
+1.21%
盘后: 4.180 0 0.00% 17:36 02/26 EST
开盘
4.000
昨收
4.130
最高
4.200
最低
3.860
成交量
14.51万
成交额
--
52周最高
12.90
52周最低
2.850
市值
4,462.99万
市盈率(TTM)
-2.1934
分时
5日
1月
3月
1年
5年
新闻
财报
公告
公司事件
分析
简况
Ameco Research分析2020年至2027年的甲型流感病毒,H3N2亚型感染药物市场分析,驱动因素,限制因素,机会,威胁,趋势,应用和增长预测
Comserve · 6天前
H3N2感染治疗市场全球行业洞察力,趋势,规模,份额,前景和机会分析,2018-2027通过Ameco Research
pune, India, Mon, 22 Feb 2021 05:51:29 / Comserve Inc. / -- H3N2 Infection Treatment market is segmented by Type, and by Application. Players, stakeholders,...
Comserve · 6天前
电晕病毒治疗的市场份额,规模,增长,2021年行业趋势,全球Covid-19对需求的影响,新兴技术,销售收入,主要参与者分析,发展状况,机会评估和2025年行业扩展策略
Feb 22, 2021 (The Expresswire) -- Global "Corona Virus Treatment Market" report 2021 presents a point by point analysis of the key trends, opportunities,...
The Express Wire · 6天前
H2N2感染治疗市场增长2021年行业份额和规模,主要发现变化,COVID-19影响,最新趋势分析,到2027年的进展状况和收入预期研究报告
Feb 18, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry.” The global “H3N2 Infection Treatment...
The Express Wire · 02/18 05:08
NanoViricides发布季度报告,称其现有资产为1839万美元,并且有“足够的现金”;还表示其NV-CoV-2候选人正在“迈向IND”
SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicinesSHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViri...
Benzinga · 02/17 11:19
360研究报告中按国家(地区)产业链结构,竞争格局,新项目和投资分析划分的病毒性结膜炎管道药物市场规模
Feb 17, 2021 (The Expresswire) -- “Global Viral Conjunctivitis Pipeline Drugs Market" analysis 2021 research report offers qualitative and quantitative...
The Express Wire · 02/17 09:49
甲型流感病毒,H3N2亚型感染药物行业2021年需求,市场趋势,区域展望,顶级制造商,业务增长和至2027年的预测|行业研究部
Feb 17, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Influenza A Virus, H3N2...
The Express Wire · 02/17 05:24
10-Q:NANOVIRICIDES,INC。
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion should be...
Edgar Online - (EDG = 10Q, 10K) · 02/16 21:42
更多
财务预测
每股收益每股净资产每股现金流
实际值(美元)
预测值(美元)
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解NNVC最新的财务预测,通过NNVC每股收益,每股净资产,每股现金流等数据分析NANOVIRICIDES近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测NNVC价格均价为14.50,最高价位14.50,最低价为14.50。
EPS
机构持股
总机构数: 38
机构持股: 304.64万
持股比例: 28.53%
总股本: 1,067.70万
类型机构数股数
增持
3
8.58万
建仓
2
2.51万
减持
6
17.38万
平仓
4
142.46万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.06%
制药与医学研究
-0.68%
高管信息
Chairman/President/Executive Director
Anil Diwan
Chief Financial Officer
Meeta Vyas
Independent Director
Stanley Glick
Independent Director
Makarand Jawadekar
Independent Director
Theodore Rokita
Independent Director
Brian Zucker
  • 分红
  • 拆股
  • 内部人交易
暂无数据
NNVC 简况
NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection. The nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company’s lead product candidate is NV-HHV-101 in the HerpeCide program, as a skin cream for the treatment of shingles rash.

微牛提供NanoViricides Inc(AMEX-NNVC)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NNVC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NNVC股票基本功能。